A positron emission tomography scanner, or PET scanner, is a medical imaging device that maps how active different tissues are inside the body. Instead of mainly showing anatomy, PET shows metabolism by tracking a small amount of radioactive tracer. This matters because many diseases, including cancers and brain disorders, change how cells use energy before large structural changes appear.
PET imaging helps doctors detect disease, plan treatment, and monitor whether therapy is working.
A PET tracer is usually attached to a molecule the body already uses, such as glucose. When the tracer decays, it emits a positron that quickly meets an electron and annihilates, producing two gamma rays traveling in nearly opposite directions. A ring of detectors around the patient records pairs of gamma rays that arrive at nearly the same time.
A computer uses millions of these events to reconstruct a 3D map of tracer concentration and metabolic activity.
Understanding Medical Technology: PET Scanners
Most clinical PET studies use a tracer called fluorodeoxyglucose, often shortened to FDG. It behaves enough like glucose for cells to take it in, but it becomes trapped inside many cells after one early chemical step. This gives the scanner time to measure where it has collected.
Fluorine-18 is useful because its activity falls by half in about 110 minutes. Hospitals must schedule the scan carefully, since the tracer is made in a cyclotron or delivered from a nearby production site. The amount used is small, and much of it leaves the body naturally through urine over the next several hours.
A detector does not directly locate a single decay point. It identifies a likely line along which the two photons traveled. This is called a line of response.
Many lines crossing the same small region suggest that tracer was present there. The computer must correct for several sources of error. Some photons are absorbed by tissue before reaching a detector.
This is called attenuation. Others scatter and change direction, which can place activity in the wrong location.
Modern systems use timing information to estimate where along a line an event happened. Better timing makes images less noisy and can reduce scanning time.
Preparation changes the quality of an FDG PET scan. Patients often fast beforehand so blood glucose and insulin levels are more stable. High blood glucose can compete with the tracer and reduce uptake in some tissues.
Recent hard exercise can make muscles use more glucose, creating bright areas that may be confusing. A patient usually rests quietly after the injection, since talking, shivering, or moving can alter normal uptake patterns. The brain normally uses a great deal of glucose.
The heart can too, depending on diet and fasting. The kidneys and bladder often appear bright because they remove the tracer from the blood.
A bright PET region is not automatic proof of cancer. Infection, inflammation, healing wounds, and active muscles can all take up FDG. Some cancers show weak uptake, especially if they grow slowly or use energy in a different way.
Doctors compare the pattern with symptoms, blood tests, earlier scans, and tissue samples when needed. PET is often combined with CT, which gives a detailed map of body structures. PET can be combined with MRI for certain brain, pelvic, or soft tissue studies.
Students should notice this key idea. PET images are measurements shaped by physics, biology, patient preparation, and computer processing. Reading them correctly depends on all of those parts.
Key Facts
- PET stands for positron emission tomography.
- A radioactive tracer emits positrons: p -> n + e+ + neutrino in beta-plus decay.
- A positron and electron annihilate to produce two gamma photons: e+ + e- -> gamma + gamma.
- Each annihilation photon has energy E = 511 keV.
- The two gamma rays travel in nearly opposite directions, about 180 degrees apart.
- Higher tracer uptake often means higher metabolic activity, such as rapid glucose use in many tumors.
Vocabulary
- PET scanner
- A medical imaging device that detects gamma rays from a radioactive tracer to create maps of activity inside the body.
- Radioactive tracer
- A substance containing an unstable isotope that is introduced into the body so its path and concentration can be detected.
- Positron
- A positively charged antimatter particle with the same mass as an electron.
- Annihilation
- The process in which a positron and an electron meet and convert their mass energy into gamma rays.
- Detector ring
- A circular array of sensors in a PET scanner that records gamma-ray pairs coming from inside the patient.
Common Mistakes to Avoid
- Thinking PET directly photographs organs is wrong because PET mainly maps tracer concentration and metabolic activity, not detailed structure.
- Assuming the tracer is the same for every scan is wrong because different tracers are chosen to study different body processes, such as glucose use, blood flow, or receptor binding.
- Forgetting that gamma rays are detected in pairs is wrong because PET reconstruction depends on two nearly opposite photons arriving at the detector ring at nearly the same time.
- Interpreting every bright PET region as cancer is wrong because normal organs, inflammation, and active brain or heart tissue can also show high tracer uptake.
Practice Questions
- 1 A PET annihilation event produces two gamma photons, each with energy 511 keV. What is the total photon energy produced in one event?
- 2 A detector ring records 2,400,000 valid coincidence events during a scan. If these events are collected over 600 seconds, what is the average coincidence rate in events per second?
- 3 A PET image shows high tracer uptake in both a tumor and the brain. Explain why high uptake does not always mean the same medical condition in every tissue.